Sign inGet started

Alam Kamran

Insider CIK 1793412 · RCKT SVP - Finance & PFO · TSHA Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TSHA Taysha Gene Therapies, Inc S Sale2026-02-042026-02-061,655$4.52 $7.5K1,442,131SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2026-01-262026-01-2723,849$4.61 $109.9K1,443,786SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2026-01-232026-01-2778,968$4.75 $375.1K1,467,635SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2026-01-122026-01-14231,000— $0231,000SEC↗
TSHA Taysha Gene Therapies, Inc A Award2026-01-122026-01-14359,000— $01,546,603SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2025-08-212025-08-2254,491$2.85 $155.3K1,187,603SEC↗
TSHA Taysha Gene Therapies, Inc F Tax w/h2025-03-112025-03-1329,843$1.69 $50.4K1,242,094SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2025-01-022025-01-03431,000— $0431,000SEC↗
TSHA Taysha Gene Therapies, Inc A Award2025-01-022025-01-03431,000— $01,271,937SEC↗
TSHA Taysha Gene Therapies, Inc F Tax w/h2024-02-022024-02-061,288$1.51 $1.9K840,937SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2024-01-022024-01-04590,413— $0590,413SEC↗
TSHA Taysha Gene Therapies, Inc A Award2024-01-022024-01-04590,413— $0842,225SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2023-12-142023-12-18187,582— $0187,582SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2023-08-242023-08-2533,000$2.33 $76.9K258,042SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2023-05-312025-04-1012,462— $012,462SEC↗
TSHA Taysha Gene Therapies, Inc A Award2023-05-312023-06-026,230— $0291,042SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2023-02-022023-02-06149,900— $0149,900SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2023-02-022023-02-0637,384— $037,384SEC↗
TSHA Taysha Gene Therapies, Inc A Award2023-02-022023-02-0618,691— $0284,812SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2022-08-232022-08-243,325$3.47 $11.5K266,121SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2022-08-222022-08-229,717$3.50 $34.0K269,446SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2022-08-192022-08-2211,482$3.75 $43.1K279,163SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2022-08-182022-08-227,476$3.87 $28.9K290,645SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2022-04-062022-04-0840,000— $040,000SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2022-02-232022-02-2580,000— $080,000SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2021-08-202021-08-209,746$16.70 $162.8K300,215SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2021-08-202021-08-202,094$17.14 $35.9K298,121SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2021-08-192021-08-20613$17.11 $10.5K309,961SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2021-08-192021-08-209,354$16.43 $153.7K310,574SEC↗
TSHA Taysha Gene Therapies, Inc S Sale2021-08-182021-08-2011,193$17.35 $194.2K319,928SEC↗
TSHA Taysha Gene Therapies, Inc A Award deriv2021-01-192021-01-2070,000— $070,000SEC↗
TSHA Taysha Gene Therapies, Inc A Award2020-09-232020-09-25331,121— $0331,121SEC↗
RCKT ROCKET PHARMACEUTICALS, IN A Award deriv2020-02-102020-02-103,000— $03,000SEC↗
RCKT ROCKET PHARMACEUTICALS, IN A Award deriv2020-02-062020-02-1025,000— $025,000SEC↗
RCKT ROCKET PHARMACEUTICALS, IN A Award deriv2019-11-042019-11-06200,000— $0200,000SEC↗